Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...
Bangalore: Increasing global warming and rising sea levels will lead to severe climate changes around the world and coff...
Bangalore: The Government of India announced on December 3, 2012, that all foreign investments in domestic pharma compa...
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry has a...
Bangalore: Opto Eurocor Healthcare, a subsidiary of Opto Circuits, launched its first Sirolimus Drug Eluting Stent (DES)...
Singapore: Sweden-based SCA plans to invest about $22.9 million (SEK 150 million) in local production of hygiene product...
Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on gene...
Singapore: Novartis launched a topical diclofenac gel, which has been formulated with Australia-based Phosphagenics' pro...
Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic...
Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehension...
Bangalore: With the advent of monsoons, India is plagued by diseases such as Leptospirosis, dengue, malaria. The difficu...
Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...
When Indian patent office granted compulsory license to Hyderabad-based Natco Pharma to market a generic version of a pa...
Mumbai: Roche Diagnostics has appointed Mr Lance Little as the chairman and managing director of Roche Diagnostics India...
Hyderabad: Dr. Reddy's Laboratories has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the US ...
My association with biotechnology started in 1950 when I was at the University of Cambridge, where Dr Watson and Dr Cric...
Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...
Mumbai: Aurobindo Pharma has reported consolidated net profit of $3.04 million (Rs 18.60 crore) during the first quarter...
